IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers

• Published in: Cancer research (Chicago, Ill.) Ill.), 2014-09, Vol.74 (17), p.4908-4921
• Main Authors: MARRA, Pierfrancesco, MATHEW, Sumi, HAYDAY, Adrian, TUTT, Andrew, GRIGORIADIS, Anita, YIN WU, KYLE-CEZAR, Fernanda, WATKINS, Johnathan, RASHID, Mamunur, DE RINALDIS, Emanuele, HESSEY, Sonya, GAZINSKA, Patrycja
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic agents; Apoptosis - genetics; Apoptosis - immunology; Biological and medical sciences; Cell Line, Tumor; Cell Movement - genetics; Cell Movement - immunology; Cell Proliferation - genetics; Female; Gynecology. Andrology. Obstetrics; Humans; Interleukin-15 - genetics; Interleukin-15 - immunology; Leukocytes, Mononuclear - immunology; Lymphocytes - immunology; Mammary gland diseases; Medical sciences; Mice; Multiple tumors. Solid tumors. Tumors in childhood (general aspects); Paracrine Communication - genetics; Paracrine Communication - immunology; Pharmacology. Drug treatments; Receptors, Interleukin-15 - genetics; Receptors, Interleukin-15 - immunology; Signal Transduction - genetics; Signal Transduction - immunology; Triple Negative Breast Neoplasms - genetics; Triple Negative Breast Neoplasms - immunology; Tumors
• ISSN: 0008-5472; 1538-7445
• DOI: 10.1158/0008-5472.can-14-0637

Despite its aggressive nature, triple-negative breast cancer (TNBC) often exhibits leucocyte infiltrations that correlate with favorable prognosis. In this study, we offer an explanation for this apparent conundrum by defining TNBC cell subsets that overexpress the IL15 immune receptor IL15RA. This receptor usually forms a heterotrimer with the IL2 receptors IL2RB and IL2RG, which regulates the proliferation and differentiation of cytotoxic T cells and NK cells. However, unlike IL15RA, the IL2RB and IL2RG receptors are not upregulated in basal-like TNBC breast cancer cells that express IL15RA. Mechanistic investigations indicated that IL15RA signaling activated JAK1, STAT1, STAT2, AKT, PRAS40, and ERK1/2 in the absence of IL2RB and IL2RG, whereas neither STAT5 nor JAK2 were activated. RNAi-mediated attenuation of IL15RA established its role in cell growth, apoptosis, and migration, whereas expression of the IL15 cytokine in IL15RA-expressing cells stimulated an autocrine signaling cascade that promoted cell proliferation and migration and blocked apoptosis. Notably, coexpression of IL15RA and IL15 was also sufficient to activate peripheral blood mononuclear cells upon coculture in a paracrine signaling manner. Overall, our findings offer a mechanistic explanation for the paradoxical association of some high-grade breast tumors with better survival outcomes, due to engagement of the immune stroma.